Cargando…
The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma
BACKGROUND: No biomarkers have been identified for the prognosis of lung squamous cell carcinoma (LUSC). Risk models based on m6A-lncRNAs help to predict survival in some cancers. However, very few studies have reported m6A-lncRNA risk models in LUSC. We aimed to construct a prognostic model based o...
Autores principales: | Huang, Hanwen, Wu, Weibin, Lu, Yiyu, Pan, Xiaofen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641337/ https://www.ncbi.nlm.nih.gov/pubmed/36389308 http://dx.doi.org/10.21037/jtd-22-1185 |
Ejemplares similares
-
Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma
por: Wu, Qiong, et al.
Publicado: (2022) -
Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer
por: Li, He, et al.
Publicado: (2022) -
Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival
por: Cardillo, Nicholas, et al.
Publicado: (2021) -
Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma
por: Zhang, Pei, et al.
Publicado: (2021) -
m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma
por: Bi, Yikang, et al.
Publicado: (2022)